ArticleTherapeutic advances in medical oncology2024

Cost-effectiveness of nivolumab combined with chemotherapy as a first-line therapy for patients with unresectable or metastatic urothelial carcinoma.

Jingwen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.